Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression
评估新诊断和复发性胶质母细胞瘤的血液学参数:骨髓抑制的预后价值和临床试验意义。
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad083
Deng, Davy; Hammoudeh, Lubna; Youssef, Gilbert; Chen, Yu-Hui; Shin, Kee-Young; Lim-Fat, Mary Jane; McFaline-Figueroa, Jose Ricardo; Chukwueke, Ugonma N; Tanguturi, Shyam; Reardon, David A; Lee, Eudocia Q; Nayak, Lakshmi; Bi, Wenya Linda; Arnaout, Omar; Ligon, Keith L; Wen, Patrick Y; Rahman, Rifaquat